Midostaurin-Related Interstitial Lung Injury in FLT3(+) Acute Myeloid Leukemia Post-Allogeneic Transplant

Lignende værker

• Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors
  af: Hagiya, Ashley, et al.
  Udgivet: (2019)
• Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
  af: Maziarz, Richard T., et al.
  Udgivet: (2020)
• First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review
  af: Hsiao, Mindy, et al.
  Udgivet: (2020)
• Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
  af: Stone, Richard M., et al.
  Udgivet: (2017)
• Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain
  af: Arenaza, Ainhoa, et al.
  Udgivet: (2019)